Related Experiment Videos
Cytogenetic studies in untreated Hodgkin's disease
H Tilly1, C Bastard, T Delastre
1Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France.
Blood
|March 15, 1991
Summary
Cytogenetic abnormalities are common in Hodgkin's disease (HD), with specific chromosomal regions frequently altered. Further molecular studies on chromosomes 12 and 13 are recommended for better understanding of HD.
Area of Science:
- Hematology
- Oncology
- Cytogenetics
Background:
- Limited data exist on cytogenetic abnormalities in Hodgkin's disease (HD).
- Correlation between cytogenetic findings and clinicopathologic features in HD is poorly understood.
Purpose of the Study:
- To investigate chromosomal abnormalities in Hodgkin's disease.
- To correlate cytogenetic findings with clinicopathologic features and survival outcomes.
- To compare cytogenetic alterations in HD with those in B-cell and T-cell lymphomas.
Main Methods:
- Chromosomal analysis of lymph nodes from 60 untreated Hodgkin's disease patients.
- Karyotype description and analysis of numerical and structural abnormalities.
- Comparison of cytogenetic findings with diffuse B-cell and T-cell lymphomas.
Main Results:
- Analyzable metaphases were obtained in 82% of patients; 55% showed chromosomal abnormalities.
- Frequent structural abnormalities involved chromosomal regions 12p11-13, 13p11-13, 3q26-28, 6q15-16, and 7q31-35.
- HD exhibited more frequent defects in specific chromosomal regions compared to B-cell and T-cell lymphomas, particularly on chromosomes 12 and 13.
Conclusions:
- Cytogenetic abnormalities are prevalent in Hodgkin's disease, with specific chromosomal regions frequently affected.
- Failure to obtain analyzable metaphases correlated with advanced stage and poor survival.
- Molecular studies in HD should focus on chromosomes 12p and 13p; larger studies are needed to determine clinical significance.